Author:
Červenka Jakub,Budková Kateřina,Suchá Rita,Vodička Petr,Voukali Eleni
Publisher
Springer International Publishing
Reference190 articles.
1. Aebersold, R., & Mann, M. (2016). Mass-spectrometric exploration of proteome structure and function. Nature. Nature Publishing Group, 537(7620), 347–355.
2. Aebersold, R., Burlingame, A. L., & Bradshaw, R. A. (2013). Western blots versus selected reaction monitoring assays: time to turn the tables? Molecular & Cellular Proteomics, 12(9), 2381–2382.
3. Agrawal, S., & Fox, J. H. (2019). Novel proteomic changes in brain mitochondria provide insights into mitochondrial dysfunction in mouse models of Huntington’s disease. Mitochondrion, 47, 318–329.
4. Akimov, S. S., Jiang, M., Kedaigle, A. J., Arbez, N., Marque, L. O., Eddings, C. R., et al. (2021). Immortalized striatal precursor neurons from Huntington’s disease patient-derived iPS cells as a platform for target identification and screening for experimental therapeutics. Human Molecular Genetics, 30(24), 2469–2487.
5. Al Shweiki, M. R., Oeckl, P., Pachollek, A., Steinacker, P., Barschke, P., Halbgebauer, S., et al. (2021). Cerebrospinal fluid levels of Prodynorphin-derived peptides are decreased in Huntington’s disease. Movement Disorders, 36(2), 492–497.